Skip to content

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Library

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 1,001 - 1,025 of 2,711

«
1
…
39
40
41
42
43
…
109
»

The New Role of Microbiome in Lung Cancer Immunotherapy

The New Role of Microbiome in Lung Cancer Immunotherapy

By: David Carbone, MD

Perioperative Therapy and Predictive Biomarkers in Early Stage Non Small Cell Lung Cancer

Perioperative Therapy and Predictive Biomarkers in Early Stage Non Small Cell Lung Cancer

By: David Gandara, MD

Immunotherapy in Kidney & Bladder Cancers

Immunotherapy in Kidney & Bladder Cancers

By: David I. Quinn, MBBS, PhD, FRACP, FACP

Management of Immune Related Adverse Events

Management of Immune Related Adverse Events

By: Elizabeth (Liz) Cooke, RN, NP, PhD

Management of Immune Related Adverse Events

Management of Immune Related Adverse Events

By: Elizabeth (Liz) Cooke, RN, NP, PhD

Advances in Car-T Cells and Other Cellular Based Therapies

Advances in Car-T Cells and Other Cellular Based Therapies

By: Elizabeth Budde, MD, PhD

Advances in Car-T Cells and Other Cellular Based Therapies

Advances in Car-T Cells and Other Cellular Based Therapies

By: Elizabeth Budde, MD, PhD

Case Study Immunotherapy

Case Study Immunotherapy

By: Gandara, David, MD

Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies

Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies

By: Gerardo Colon-Otero, MD

Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies

Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies

By: Gerardo Colon-Otero, MD

Immunotherapy and HER2 Targeted Updates in Esophageal Cancer

Immunotherapy and HER2 Targeted Updates in Esophageal Cancer

By: Harry H. Yoon, MD, MHS

Adjuvant/Neo-adjuvant Systemic Therapy

Adjuvant/Neo-adjuvant Systemic Therapy

By: Heather Wakelee, MD

Adjuvant/Neo-Adjuvant Systemic Therapy

Adjuvant/Neo-Adjuvant Systemic Therapy

By: Heather Wakelee, MD

Case Study on Immunotherapy Reaction

Case Study on Immunotherapy Reaction

By: Helen Shih

Immunotherapy in Oncology Session I

Immunotherapy in Oncology Session I

By: Hossein Borghaei, David Quinn, Sanjiv Agarwala

The Importance of TIME in Cancer Fight: How to Target It?

The Importance of TIME in Cancer Fight: How to Target It?

By: Hossein Borghaei, DO

Future Challenges for Immunotherapy in the Fight Against NSCLC

Future Challenges for Immunotherapy in the Fight Against NSCLC

By: Hossein Borghaei, DO

Future Challenges for Immunotherapy in the Fight Against NSCLC

Future Challenges for Immunotherapy in the Fight Against NSCLC

By: Hossein Borghaei, DO

The Importance of TIME in Cancer Fight: How to Target It?

The Importance of TIME in Cancer Fight: How to Target It?

By: Hossein Borghaei, DO

Immunotherapy in Lung Cancer

Immunotherapy in Lung Cancer

By: Hossein Borghaei, DO, MS

Developmental Therapeutics and Novel Agents

Developmental Therapeutics and Novel Agents

By: Ignacio Gil-Bazo, MD

Gene Therapies and Immunotherapy Updates in Solid Tumor Malignancies

Gene Therapies and Immunotherapy Updates in Solid Tumor Malignancies

By: Isabel Houlzet, PharmD, BCOP, BCPS & Qureshi, PharmD, BCOP

Gene Therapies and Immunotherapy Updates in Solid Tumor Malignancies

Gene Therapies and Immunotherapy Updates in Solid Tumor Malignancies

By: Isabel Houlzet, PharmD, BCOP, BCPS & Qureshi, PharmD, BCOP

Immunotherapy and Side Effect Management: Challenging Cases

Immunotherapy and Side Effect Management: Challenging Cases

By: Jeanelle King, PA-C

Novel Immunotherapy Approach and Targeted Therapy in Melanoma

Novel Immunotherapy Approach and Targeted Therapy in Melanoma

By: Jennifer L. McQuade, MD, MS, MA, Lac

«
1
…
39
40
41
42
43
…
109
»

© 2024 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok